Axogen, Inc. Common Stock AXGN
HEALTHCARE · MEDICAL DEVICESi
Market dataready · fetched 2026-11-06T21:24:30.535Z
Delta surfaceAlpaca · derived absolute-delta buckets · 2026-11-20
Calculation methodologyOptions historyIV: ThetaData historical Greeks, equal-weight mean of call/put 50-delta IV across the next four listed Friday-cycle expirations, including holiday shifts verified against ThetaData’s market calendar. Missing inputs leave gaps. Skew: equal-weight mean of put minus call IV across those four expirations. IV-implied move history: mean of each expiration’s average call/put IV multiplied by the square root of remaining calendar days divided by 365.25; percentage of spot, not a quoted straddle premium.
History dataPriceAlpaca · sip · 2026-11-06T21:09:13.609290589Z
FundamentalsAlpha Vantage · ready · quarter 2026-09-30 · fetched 2026-11-06T21:24:30.160729+00:00
Axogen, Inc. Common Stock options
Table
| Delta | Calls | Puts | ||||
|---|---|---|---|---|---|---|
| Pseudo strike | IV | B/E move | Pseudo strike | IV | B/E move | |
| 20Δ | 54.39 | 50.1% | 10.7% | 45.92 | 49.3% | 8.9% |
| 25Δ | 53.67 | 51.7% | 9.8% | 46.60 | 50.4% | 8.1% |
| 30Δ | 52.95 | 53.3% | 8.9% | 47.29 | 51.5% | 7.2% |
| 35Δ | 52.23 | 54.9% | 8.0% | 47.97 | 52.5% | 6.4% |
| 40Δ | 51.51 | 56.6% | 7.1% | 48.66 | 53.6% | 5.6% |
| 45Δ | 50.80 | 58.2% | 6.1% | 49.35 | 54.7% | 4.7% |
| 50Δ | 50.08 | 59.8% | 5.2% | 50.03 | 55.6% | 3.9% |
| 55Δ | 49.27 | 60.3% | 4.6% | 50.69 | 53.9% | 3.4% |
| 60Δ | 48.45 | 60.7% | 4.0% | 51.35 | 52.2% | 3.0% |
| 65Δ | 47.63 | 61.1% | 3.4% | 52.00 | 50.4% | 2.5% |
| 70Δ | 46.81 | 61.6% | 2.8% | 52.66 | 48.7% | 2.0% |
| 75Δ | 45.99 | 62.0% | 2.2% | 53.32 | 47.0% | 1.5% |
| 80Δ | 45.17 | 62.4% | 1.6% | 53.98 | 45.3% | 1.1% |
20Δ
- Pseudo strike
- 54.39
- IV
- 50.1%
- B/E move
- 10.7%
- Pseudo strike
- 45.92
- IV
- 49.3%
- B/E move
- 8.9%
25Δ
- Pseudo strike
- 53.67
- IV
- 51.7%
- B/E move
- 9.8%
- Pseudo strike
- 46.60
- IV
- 50.4%
- B/E move
- 8.1%
30Δ
- Pseudo strike
- 52.95
- IV
- 53.3%
- B/E move
- 8.9%
- Pseudo strike
- 47.29
- IV
- 51.5%
- B/E move
- 7.2%
35Δ
- Pseudo strike
- 52.23
- IV
- 54.9%
- B/E move
- 8.0%
- Pseudo strike
- 47.97
- IV
- 52.5%
- B/E move
- 6.4%
40Δ
- Pseudo strike
- 51.51
- IV
- 56.6%
- B/E move
- 7.1%
- Pseudo strike
- 48.66
- IV
- 53.6%
- B/E move
- 5.6%
45Δ
- Pseudo strike
- 50.80
- IV
- 58.2%
- B/E move
- 6.1%
- Pseudo strike
- 49.35
- IV
- 54.7%
- B/E move
- 4.7%
50Δ
- Pseudo strike
- 50.08
- IV
- 59.8%
- B/E move
- 5.2%
- Pseudo strike
- 50.03
- IV
- 55.6%
- B/E move
- 3.9%
55Δ
- Pseudo strike
- 49.27
- IV
- 60.3%
- B/E move
- 4.6%
- Pseudo strike
- 50.69
- IV
- 53.9%
- B/E move
- 3.4%
60Δ
- Pseudo strike
- 48.45
- IV
- 60.7%
- B/E move
- 4.0%
- Pseudo strike
- 51.35
- IV
- 52.2%
- B/E move
- 3.0%
65Δ
- Pseudo strike
- 47.63
- IV
- 61.1%
- B/E move
- 3.4%
- Pseudo strike
- 52.00
- IV
- 50.4%
- B/E move
- 2.5%
70Δ
- Pseudo strike
- 46.81
- IV
- 61.6%
- B/E move
- 2.8%
- Pseudo strike
- 52.66
- IV
- 48.7%
- B/E move
- 2.0%
75Δ
- Pseudo strike
- 45.99
- IV
- 62.0%
- B/E move
- 2.2%
- Pseudo strike
- 53.32
- IV
- 47.0%
- B/E move
- 1.5%
80Δ
- Pseudo strike
- 45.17
- IV
- 62.4%
- B/E move
- 1.6%
- Pseudo strike
- 53.98
- IV
- 45.3%
- B/E move
- 1.1%
Options history
Table
| Date | IV (%) |
|---|---|
| 56.74% | |
| 52.25% | |
| 51.08% | |
| 55.87% | |
| 55.21% | |
| 61.37% | |
| 50.19% | |
| 49.69% | |
| 49.92% | |
| 50.49% | |
| 50.81% | |
| 50.38% | |
| 51.66% | |
| 53.78% | |
| 54.06% | |
| 52.67% | |
| 52.94% | |
| 58.04% | |
| 67.19% | |
| 73.89% | |
| 57.08% | |
| 57.38% | |
| 57.14% | |
| 58.72% | |
| 72.86% | |
| 73.80% | |
| 79.00% | |
| 83.69% | |
| 81.98% | |
| 81.44% | |
| 78.52% | |
| 82.01% | |
| 77.10% | |
| 92.62% | |
| 96.66% | |
| 76.00% | |
| 75.07% | |
| 77.84% | |
| 74.49% | |
| 76.92% | |
| 83.15% | |
| 55.43% | |
| 52.45% | |
| 51.34% |
Medical Devices
BBNX
Beta Bionics, Inc., a commercial-stage medical device company, engages in the design, development, and commercialization of solutions to enhance the health and quality of life of…
More →BFLY
Butterfly Network, Inc., a digital health company, develops, manufactures, and markets ultrasound imaging solutions in the United States and internationally. The company is…
More →BIO
Bio-Rad Laboratories, Inc. is an American developer and manufacturer of specialized technological products for the life science research and clinical diagnostics markets.
More →BRKR
Bruker Corporation develops, manufactures and distributes scientific instruments and analytical and diagnostic solutions in the United States, Europe, Asia Pacific, and…
More →BSX
Description unavailable
More →BVS
Bioventus Inc., a medical device company, focuses on developing and commercializing clinical treatments that involve and enhance the body's natural healing process in the United…
More →